Trinity Legacy Partners LLC Sells 156 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trinity Legacy Partners LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.5% in the third quarter, HoldingsChannel reports. The fund owned 850 shares of the medical equipment provider’s stock after selling 156 shares during the period. Trinity Legacy Partners LLC’s holdings in Intuitive Surgical were worth $414,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at about $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC raised its position in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares in the last quarter. Finally, Delos Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.7 %

Shares of ISRG opened at $524.28 on Friday. The stock has a market cap of $186.74 billion, a PE ratio of 84.29, a PEG ratio of 4.99 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $269.49 and a 12-month high of $525.00. The business has a 50-day simple moving average of $492.30 and a two-hundred day simple moving average of $450.05.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Robert Desantis sold 240 shares of the stock in a transaction on Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 68,246 shares of company stock worth $33,839,308. Insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ISRG shares. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Robert W. Baird raised their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Mizuho raised their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Barclays boosted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.